NUVL
Price
$92.52
Change
+$2.10 (+2.32%)
Updated
Oct 17 closing price
Capitalization
6.67B
19 days until earnings call
Intraday Buy/Sell Signals
RVMD
Price
$54.10
Change
+$4.42 (+8.90%)
Updated
Oct 17 closing price
Capitalization
10.11B
18 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

NUVL vs RVMD

Header iconNUVL vs RVMD Comparison
Open Charts NUVL vs RVMDBanner chart's image
Nuvalent
Price$92.52
Change+$2.10 (+2.32%)
Volume$351.66K
Capitalization6.67B
Revolution Medicines
Price$54.10
Change+$4.42 (+8.90%)
Volume$4.59M
Capitalization10.11B
NUVL vs RVMD Comparison Chart in %
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NUVL vs. RVMD commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NUVL is a Hold and RVMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (NUVL: $92.52 vs. RVMD: $54.10)
Brand notoriety: NUVL and RVMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NUVL: 86% vs. RVMD: 214%
Market capitalization -- NUVL: $6.67B vs. RVMD: $10.11B
NUVL [@Biotechnology] is valued at $6.67B. RVMD’s [@Biotechnology] market capitalization is $10.11B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NUVL’s FA Score shows that 0 FA rating(s) are green whileRVMD’s FA Score has 0 green FA rating(s).

  • NUVL’s FA Score: 0 green, 5 red.
  • RVMD’s FA Score: 0 green, 5 red.
According to our system of comparison, NUVL is a better buy in the long-term than RVMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NUVL’s TA Score shows that 6 TA indicator(s) are bullish while RVMD’s TA Score has 5 bullish TA indicator(s).

  • NUVL’s TA Score: 6 bullish, 4 bearish.
  • RVMD’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, NUVL is a better buy in the short-term than RVMD.

Price Growth

NUVL (@Biotechnology) experienced а +5.02% price change this week, while RVMD (@Biotechnology) price change was +12.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

NUVL is expected to report earnings on Nov 06, 2025.

RVMD is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($10.1B) has a higher market cap than NUVL($6.67B). RVMD YTD gains are higher at: 23.685 vs. NUVL (18.191). NUVL has higher annual earnings (EBITDA): -362.01M vs. RVMD (-883.71M). RVMD has more cash in the bank: 2.14B vs. NUVL (1.01B). NUVL (0) and RVMD (0) have equivalent revenues.
NUVLRVMDNUVL / RVMD
Capitalization6.67B10.1B66%
EBITDA-362.01M-883.71M41%
Gain YTD18.19123.68577%
P/E RatioN/AN/A-
Revenue00-
Total Cash1.01B2.14B47%
Total DebtN/A133M-
TECHNICAL ANALYSIS
Technical Analysis
NUVLRVMD
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 11 days ago
78%
Bearish Trend 11 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 5 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RGPAX23.57N/A
N/A
RBC Global Opportunities A
EHSTX26.92N/A
N/A
Eaton Vance Large-Cap Value A
MNDFX8.72N/A
N/A
Manning & Napier Disciplined Value I
FITLX29.52N/A
N/A
Fidelity U.S. Sustainability Index
NZDGBP0.43N/A
N/A
New Zealand Dollar - United Kingdom Pound

NUVL and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVL has been loosely correlated with XENE. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVL jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVL
1D Price
Change %
NUVL100%
+2.32%
XENE - NUVL
61%
Loosely correlated
-1.28%
RVMD - NUVL
60%
Loosely correlated
+8.90%
CGON - NUVL
59%
Loosely correlated
-0.93%
XNCR - NUVL
59%
Loosely correlated
-1.20%
IDYA - NUVL
58%
Loosely correlated
+5.67%
More

RVMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with NUVL. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
+8.90%
NUVL - RVMD
58%
Loosely correlated
+2.32%
OCUL - RVMD
52%
Loosely correlated
-2.95%
CLDX - RVMD
52%
Loosely correlated
+1.05%
CGON - RVMD
51%
Loosely correlated
-0.93%
KYMR - RVMD
50%
Loosely correlated
-1.04%
More